Acusphere AI-700 Ultrasound Agent Promising For Cardiac Perfusion
This article was originally published in The Gray Sheet
Executive SummaryAcusphere's AI-700 enhanced ultrasound contrast agent appears to aid detection of areas of low myocardial perfusion in high concordance with nuclear medicine, according to animal data from two studies presented March 9 at the annual scientific session of the American College of Cardiology meeting in New Orleans.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.